Mounjaro and Blood Pressure: Does Tirzepatide Lower It? (2026)

Mostly good news: tirzepatide tends to modestly lower blood pressure, not raise it. Mounjaro is tirzepatide — a dual GIP/GLP-1 receptor agonist, and the same molecule sold for weight management as Zepbound. Across the SURMOUNT and SURPASS trial programs, tirzepatide was associated with a small, dose-related drop in systolic blood pressure, and a dedicated 24-hour ambulatory blood pressure monitoring (ABPM) substudy of SURMOUNT-1 confirmed a reduction of several mmHg versus placebo, driven largely by weight loss.^[1][2] For most people with overweight, obesity, or type 2 diabetes, a gentle reduction in blood pressure is a benefit. But there is an important caution that ties into the drug's other effects: if your blood pressure is falling and you become dehydrated from gastrointestinal side effects, or you already take blood-pressure-lowering medications such as diuretics, ACE inhibitors, or ARBs, you can end up with orthostatic hypotension (lightheadedness or dizziness on standing) or excessively low blood pressure. As you lose weight, your prescriber may need to adjust your blood-pressure medications — and you should not change them on your own. See our Mounjaro drug page for the at-a-glance overview, and our companion guide on blood pressure on semaglutide for the closely related single-incretin medicine. This is general educational information, not medical advice — your prescriber manages your care.

Does Mounjaro lower blood pressure?

For most people, yes — modestly. Across the randomized evidence, tirzepatide is associated with a small but consistent drop in systolic blood pressure (the top number), and the effect tends to be dose-related — larger reductions at higher doses, tracking with greater weight loss. The pivotal SURMOUNT-1 trial of tirzepatide for obesity reported reductions in systolic blood pressure as part of its cardiometabolic findings, alongside the substantial weight loss.^[1] More directly, a dedicated 24-hour ambulatory blood pressure monitoring substudy of SURMOUNT-1 — which measures blood pressure repeatedly across a full day and night rather than at a single clinic visit — confirmed that tirzepatide produced a meaningful reduction in 24-hour systolic blood pressure versus placebo in adults with a body mass index of 27 or higher.^[2]

That is the opposite of what many people fear when starting a new medication. Rather than driving blood pressure up, tirzepatide gently eases it down. The benefit, though, is exactly what creates the caution further down this guide: if your blood pressure is already being managed with medication, an additional downward push can occasionally tip you into blood pressure that is too low. Mounjaro is the type 2 diabetes brand of tirzepatide and Zepbound is the weight-management brand; because they are the same molecule at the same doses, the blood-pressure findings from the SURMOUNT (obesity) and SURPASS (diabetes) programs apply across both.^[1]

Why tirzepatide lowers blood pressure

The reduction is not a single mechanism but mostly a consequence of weight loss, with a possible additional direct contribution from the incretin pathways. The main drivers:

• Weight loss does most of the work. Tirzepatide produces large reductions in body weight, and as people shed excess fat mass the cardiovascular load eases and blood pressure tends to fall. In SURMOUNT-1 the blood-pressure improvement traveled alongside the substantial weight loss, which is the single largest contributor.^[1]
• A dose-related, weight-linked effect. The blood-pressure reduction generally tracks with dose and with how much weight a person loses — larger reductions at higher doses and greater weight loss, smaller ones when weight change is modest. The 24-hour ABPM substudy showed the lower blood pressure was sustained across a full day, not just at a clinic check.^[2]
• Possible direct vascular and natriuretic effects. Beyond weight loss, incretin receptor activity has been linked to favorable effects on blood vessels and to the kidneys handling sodium (a natriuretic effect), which could contribute a further small blood-pressure-lowering nudge on top of the weight-driven change.^[2]

The caution: when low blood pressure becomes a problem

A modest blood-pressure reduction is usually welcome — but a few overlapping situations can turn it into excessively low blood pressure or orthostatic hypotension (a drop in blood pressure when you stand up that causes lightheadedness or dizziness). The risk factors stack:

• Dehydration from GI side effects. Nausea, vomiting, and diarrhea are common on tirzepatide, and the fluid losses they cause can lower your circulating blood volume — which can push blood pressure down further and bring on dizziness, especially on standing. Staying hydrated is both a comfort measure and a genuine safety measure, since dehydration is also the main route to the label's acute-kidney-injury risk.^[3]
• Existing blood-pressure medications. If you already take diuretics, ACE inhibitors, ARBs, or other anti-hypertensives, their effect adds to tirzepatide's blood-pressure-lowering effect and to your weight-loss-driven drop. As your weight falls, the dose that was right for your heavier body may become too strong, leaving your blood pressure lower than intended.^[3]
• Symptoms of overshoot. Lightheadedness or dizziness on standing, fainting or near-fainting, blurred vision, or unusual fatigue can all signal that your blood pressure has dropped too far — particularly if they cluster with GI symptoms or after a dose increase. Report these to your prescriber so your medications can be reviewed.^[4]

The takeaway is not to avoid Mounjaro — for most people the blood-pressure effect is a benefit — but to recognize that your prescriber may need to adjust your blood-pressure medications as you lose weight. This is a routine, expected part of supervised treatment. The one rule that matters: do not stop or reduce a blood-pressure medication on your own. Stopping anti-hypertensives without guidance can cause your blood pressure to rebound dangerously high; the safe path is to report symptoms and let your clinician retitrate.^[4]

Blood pressure down, heart rate slightly up

One more pairing is worth understanding, because it can look contradictory. While tirzepatide modestly lowers blood pressure, it also tends to produce a small increase in resting heart rate — typically on the order of a few beats per minute on average. Both changes are well-recognized incretin-medicine effects, and for most people both are mild and well-tolerated: a gentle fall in blood pressure alongside a modest rise in pulse. We cover the pulse side of this pairing in detail in Mounjaro and heart rate.^[3]

What does warrant a conversation with your prescriber is a heart-rate change that is large, accompanied by palpitations, chest discomfort, or breathlessness, or paired with the low-blood-pressure symptoms above. In isolation, a few extra beats per minute on a stable dose is generally part of the expected profile rather than a warning sign — but as with everything here, your clinician is the one who decides what is normal for you given your other conditions and medications.^[4]

Practical, prescriber-directed steps

Because the blood-pressure effect is usually a benefit that occasionally overshoots, the practical steps are about monitoring and communication, not avoidance. The following are general, commonly-discussed strategies — all of them are prescriber-directed. Do not change your Mounjaro dose, start supplements, or adjust other medications without talking to your clinician.

• Monitor your blood pressure at home if you take BP medication. A simple home cuff, used at consistent times, lets you and your prescriber see the trend as you lose weight — and catch readings that are drifting too low before they cause symptoms.^[4]
• Report symptomatic low blood pressure. Tell your prescriber about lightheadedness or dizziness on standing, fainting or near-fainting, or unusual fatigue — these can mean your blood pressure has dropped too far and your medications need adjusting.^[4]
• Stay hydrated, especially during GI symptoms. Keep fluids and electrolytes steady through the day, and pay extra attention during any nausea, vomiting, or diarrhea, since dehydration both lowers blood pressure and is the main pathway to the label's acute-kidney-injury risk.^[3]
• Review your medications with your prescriber as your weight drops. Expect that the right dose of a diuretic, ACE inhibitor, ARB, or other anti-hypertensive may change as you lose weight; your clinician can retitrate or reduce them safely.^[3]
• Never stop a blood-pressure medication on your own. Abruptly stopping anti-hypertensives can cause a dangerous rebound in blood pressure. Any change should be made with your prescriber's guidance, not unilaterally.^[4]
• Stand up gradually. If you are prone to lightheadedness on standing, rising slowly from sitting or lying down gives your circulation time to adjust and reduces the chance of an orthostatic dizzy spell while your prescriber sorts out the right medication doses.^[4]

If you are choosing where to start or continue tirzepatide under proper supervision, a legitimate provider checks your blood pressure, knows your other medications, and follows up as you lose weight — exactly the monitoring that keeps the blood-pressure benefit a benefit. For the at-a-glance overview see the Mounjaro drug page; for the pulse side of the picture, see Mounjaro and heart rate; and for the closely related single-incretin medicine, see blood pressure on semaglutide.